Product Information
IVABRADINE HCL 5 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.7713 per EA under NDC 62332067960. Its NADAC has been published 67 times since Mar 19, 2025.
Strength
5 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332067960
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IVABRADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215238On Market Since
12/20/2024
Pharmacological Classes
Price Statistics
The NADAC for IVABRADINE HCL 5 MG TABLET has been published 67 times since Mar 19, 2025, and over the history we have for it it has declined 79.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7713 per EA |
|---|---|
| All-time high | $3.8360 (Apr 16, 2025) |
| All-time low | $0.7713 (Jun 17, 2026) |
| 52-week high | $3.1866 |
| 52-week low | $0.7713 |
| Median price | $2.9854 |
| Average price | $2.3917 |
| Largest weekly change | -40.9% (Feb 18, 2026) |
| Weeks tracked | 67 |
| Tracking since | Mar 19, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IVABRADINE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IVABRADINE HCL 5 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.7713 per EA (NDC 62332067960), effective Jun 24, 2026.
How has the price of IVABRADINE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for IVABRADINE HCL 5 MG TABLET has declined 79.9%. It has been tracked across 67 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for IVABRADINE HCL 5 MG TABLET?
Since Mar 19, 2025, the NADAC for IVABRADINE HCL 5 MG TABLET has ranged from a low of $0.7713 (Jun 17, 2026) to a high of $3.8360 (Apr 16, 2025), with a median of $2.9854 per EA.
Are there cheaper alternatives to IVABRADINE HCL 5 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as IVABRADINE HCL 5 MG TABLET, but none are currently priced below it.
Who manufactures IVABRADINE HCL 5 MG TABLET?
IVABRADINE HCL 5 MG TABLET (NDC 62332067960) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification